RESTEM is committed to the development of technologies that ensure our world’s health and wellbeing.
Presently, we are in clinical studies for COVID19 presenting solutions for unmet needs.
We are proud donors of cGMP stem cells for clinical studies. Presently, moving forward with clinical studies on Autoimmune diseases, COVID19, Duchenne Muscular Dystrophy and Heart Failure secondary issues following left ventricular assisted.
Restoring Your Health Through Stem Cell Biology
Over the last decade, RESTEM has been developing leading-edge studies on stem cell biology and genome technology with the sole objective of extending and enhancing the quality of human life.